Gene · 963
Papers1,502
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 1,502
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of PD-1-Related Genes as Prognostic Biomarkers in Lung Adenocarcinoma. | Hum Mutat | 2026 | 42643623 | PubTator, text mining | PubMed |
| The translational potential of m6A RNA methylation in DKD: emerging biomarkers for early detection and targeted therapies. | Front Med (Lausanne) | 2026 | 42559138 | PubTator, text mining | PubMed |
| Single cell multi-omics enables high-resolution identification and functional purification of human acute myeloid leukemia stem cells. | bioRxiv | 2026 | 42523402 | PubTator, text mining | PubMed |
| Systems-level analyses and clinical validation highlight CD53 as a diagnostic and prognostic marker in lung adenocarcinoma. | Front Cell Dev Biol | 2026 | 42368459 | PubTator, text mining | PubMed |
| Extracellular vesicle cargo dynamics in the bone marrow microenvironment: from hematopoietic homeostasis to malignant transformation. | Extracell Vesicle | 2026 | 42344609 | PubTator, text mining | PubMed |
| Integrative transcriptomic and systems biology analysis of public SLE datasets identifies immune regulatory pathways. | J Comput Aided Mol Des | 2026 | 42295464 | PubTator, text mining | PubMed |
| Exploring key biomarkers associated with axillary lymph node metastasis in breast cancer using single-cell RNA sequencing and Mendelian randomization. | Int J Biol Markers | 2026 | 42121358 | PubTator, text mining | PubMed |
| Pathogenic implication of the CD53 tetraspanin in immune and cancer cells. | Biochim Biophys Acta Mol Cell Res | 2026 | 41921791 | PubTator, text mining | PubMed |
| Integrated bioinformatics and machine learning to explore the common mechanisms and potential biomarkers between periodontitis and preterm birth. | Front Cell Dev Biol | 2026 | 41799432 | PubTator, text mining | PubMed |
| Integrating computational engines to identify TSPAN6 as a migrasome-associated target for immunotherapy sensitization. | Front Immunol | 2026 | 41782878 | PubTator, text mining | PubMed |
| PLD3: In vitro functional characterization and autophagy pathway-mediated regulatory effects in gastric cancer. | Biochem Biophys Res Commun | 2026 | 41780338 | PubTator, text mining | PubMed |
| A New Subpopulation of Extracellular Vesicles Harvested from Osteogenically Induced Mesenchymal Stromal Cells of Surgical Site-Released Tissue. | Biomolecules | 2026 | 41750359 | PubTator, text mining | PubMed |
| Controlling Biogenesis and Engineering of Exosomes to Inhibit Growth and Promote Death in Glioblastoma Multiforme. | Brain Sci | 2026 | 41750131 | PubTator, text mining | PubMed |
| Ensemble molecular mimicry correlates with antibody cross-reactivity in proteome-wide studies. | Front Immunol | 2026 | 41743743 | PubTator, text mining | PubMed |
| Causal Implication of CD52-Driven Immune Dysregulation in Sarcopenic Obesity: Integrating Mendelian Randomization and Multiomics Profiling. | Clin Interv Aging | 2026 | 41726179 | PubTator, text mining | PubMed |
| Bioengineering of extracellular vesicles with scaffold proteins for drug delivery. | J Nanobiotechnology | 2026 | 41680844 | PubTator, text mining | PubMed |
| Single-cell spatial transcriptomics uncovers niches that govern response to PD-1/PD-L1 blockade in cutaneous squamous cell carcinoma. | J Immunother Cancer | 2026 | 41617396 | PubTator, text mining | PubMed |
| SputOMICs identifies common and distinct markers in cystic fibrosis and chronic obstructive pulmonary disease. | Res Sq | 2025 | 40894026 | PubTator, text mining | PubMed |
| Recent Advances in PET and Radioligand Therapy for Lung Cancer: FDG and FAP. | Cancers (Basel) | 2025 | 40805245 | PubTator, text mining | PubMed |
| A novel necroptosis related prognostic signature for skin cutaneous melanoma based on transcriptome and single cell sequencing analysis. | Sci Rep | 2025 | 40596554 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/963/papers